Your browser doesn't support javascript.
loading
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
Antonarakis, Emmanuel S; Lu, Changxue; Luber, Brandon; Liang, Chao; Wang, Hao; Chen, Yan; Silberstein, John L; Piana, Danilo; Lai, Zhao; Chen, Yidong; Isaacs, William B; Luo, Jun.
Afiliação
  • Antonarakis ES; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: eantona1@jhmi.edu.
  • Lu C; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Luber B; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Liang C; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Wang H; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Chen Y; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Silberstein JL; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Piana D; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lai Z; Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Chen Y; Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Isaacs WB; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Luo J; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jluo1@jhmi.edu.
Eur Urol ; 74(2): 218-225, 2018 08.
Article em En | MEDLINE | ID: mdl-29439820
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Mutação em Linhagem Germinativa / Enzimas Reparadoras do DNA / Neoplasias de Próstata Resistentes à Castração / Antagonistas de Androgênios / Androstenos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Mutação em Linhagem Germinativa / Enzimas Reparadoras do DNA / Neoplasias de Próstata Resistentes à Castração / Antagonistas de Androgênios / Androstenos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2018 Tipo de documento: Article